De Maeseneer Daan

Medical Oncologist. Palliative care and uro-oncology focus. Views & tweets are my own.

[De Maeseneer Daan @daandm]

#APCCC26 Fantastic overview! Thanks to @silkegillessen and Aurelius Omlin! @OncoAlert @weoncologists #APCCC Run!

[OncoAlert @OncoAlert]

Day Two of #BLADDR25
#GlobalForum25 in Portugal 🇵🇹
Kicking off with a presentation from Dr. Eva Comperat of Vienna, Austria🇦🇹 & Paris, France🇫🇷

Session 🔟Years of BLADDR
#BladderCancer (Past to Present):
The Pathologist Viewpoint

@Ric_Campi
@achoud72
@daandm
@bm_deruiter
@mdesantis234
@nachoduranm
@fontev1
@PGrivasMDPhD
@DrFelixGuerrero
@bkonety
@Uro_Kris
@UroMoschini
@PignotG
@HenningPlage
@tompowles1
@DanieleRaggi83
@b_szabados
@BenteThoft
@UrsulaVogl
@nataliagandur
@DrRishabhOnco
@mirrorsmed

[De Maeseneer Daan @daandm]

Arrived in Lisbon for #renalc25 and #bladdr25. Great days ahead! @mirrorsmed

[De Maeseneer Daan @daandm]

@ First Presidential #esmo2025 !

[Mirrors of Medicine @mirrorsmed]

Which treatment would you offer to Charlize, recently diagnosed with metastatic #BladderCancer?

📌Compare your choice with your peers and check the expert opinions in our updated case-based #CME course “First-line therapy of synchronous and metachronous metastatic UCa”: https://t.co/StmSaSx57s

Multidisciplinary expert panel @daandm @ElieRassy @amerseburger @b_szabados @achoud72 @Shaista_Hafeez @cnsternberg @BlancJeremy @mdesantis234 @UrsulaVogl Frederiek D’Hondt, Aristotelis Bamias, Arnoud Templeton, Richard Cathomas, Rob Jones

@OncoAlert

[De Maeseneer Daan @daandm]

Enter TheKiteMag's giveaway to win prizes from Mystic, Lieuwe, Duotone, Slingshot & Levitaz. #Kiteboarding https://t.co/mi1WHSmWXY

[De Maeseneer Daan @daandm]

@tomvandenbulcke Zeer sterk #diw vibes met ‘Hoge School’ bijdrage… kan vlotter/moderner.

[Mirrors of Medicine @mirrorsmed]

The programme for #BLADDR23 in Malaga, Spain is online! 

Looking forward to seeing the faculty, community and partners there from 1– 2 December 2023! 

Don’t forget to get your early bird tickets before 22 October 2023. 

Want to know more? See the programme here

https://t.co/dztVNez4FD

@UrsulaVogl @PaulSargos @DrFelixGuerrero @xmaldona @IraniJacques @b_szabados @daandm @achoud72 @fontev1 @LAUrology_NL @Achard_Verane @nachoduranm @evacomperat @bkonety @E_Laukhtina @UroMoschini @OncoAlert

[Darren Rovell @darrenrovell]

College graduation speeches are often evergreen. They can be given at any time, similar from decade to decade.

Which is why Illinois Governor J. B. Pritzker’s “How To Spot An Idiot” at Northwestern’s graduation is so genius.

It is the speech for TODAY

[Mathieu Spaas @MathieuSpaas]

📣We just published final results of our CHEERS trial @JAMAOnc investigating the combination of subtotal subablative SBRT ☢️ with anti-PD-(L)1 monotherapy 💉 in pts with advanced solid tumors https://t.co/Tdqxk72OGi

[Camille Berquin @camilleberquin]

📣New Publication Alert: Radiotherapy use in muscle-invasive bladder cancer by @FlorVerghote

❗️Very pleased & proud to be part of this MDT working on the optimization of care for bladder cancer patients @fontev1 @CharlesPraet @uzgent @ugent_fge

https://t.co/BD9nDB9FaK

[Tijl De Bie @TijlDeBie]

Op 11 maart schreef @jdceulaer over het 'echte' verhaal van de pandemie.
https://t.co/a2ytCn0jDv

Vandaag is mijn Recht van Antwoord verschenen, enkel in de gedrukte versie van @demorgen.

Dit bleek onmogelijk zonder genereuze juridische hulp. Recht is er niet voor iedereen.

1/3

[De Maeseneer Daan @daandm]

@OCorbhuiPol @Millar_Colin Regular season points count only for half during play-offs. Winner of PO takes championship.

[De Maeseneer Daan @daandm]

I always use this slide to explain why we can propose screening in PCa.

[Nick James @Prof_Nick_James]

You don’t appear to have read the article which explains the study, it’s aims, funding etc. The current “informed choice” GP model fails 1000s every year. We are exploring ways to improve on it. As a GP surely you should welcome studies like this.

[Dr. Glaucomflecken @DGlaucomflecken]

Elsevier is losing editors

[CRIG @crighent]

Ready for day 2 💪!

[De Maeseneer Daan @daandm]

@tomvandenbulcke Dikke proficiat en zeer goed werk! Hopelijk geen Chinese ambities …
Wanneer kaagent@mastodon ?

[Simon C @scserendipity1]

@ChrisSweens1 @brookmans76 @DrSpratticus Thanks Chris 🙏 so at present (if you could) would you use ARI + PARPi in all comers? I worry about toxicity, adherence and Magnitude of benefit @Ecastromarcos @EfstathiouEleni @quimmateo @AdamSharpMedOnc @AzadOncology @neerajaiims

[Bertrand Delsuc @BertrandBio]

AstraZeneca $AZN and Merck $MRK present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium

mOS 42.1 vs 34.7mo
OS HR 0.81 - 95%CI 0.67-1.00; p=0.0544 #sadthrombone
https://t.co/Dmk7DeBudm